Biochip Industry Forecast PowerPoint PPT Presentations

Research Beam added report on "China Biochip Industry Development, Size, Share, Trends, Segmentation, Growth, Technology, Opportunity, Analysis and Forecast 2015" Enquiry about report: http://www.researchbeam.com/china-biochip-industry-2015-deep-research-report-market/enquire-about-report

According to the latest research report by IMARC Group, The global biochips market size reached USD 22.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 76.0 Billion by 2033, exhibiting a growth rate (CAGR) of 13.02% during 2025-2033. More Info:- https://www.imarcgroup.com/biochips-market

According to the latest research report by IMARC Group, The global biochips market size reached US$ 19.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.3 Billion by 2032, exhibiting a growth rate (CAGR) of 13.7% during 2024-2032. More Info:- https://www.imarcgroup.com/biochips-market

Biochips market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biochips market will be able to gain the upper hand as they use the report as a powerful resource.

Asia-Pacific Food Safety Testing Market By Testing Type (Allergen Testing, Pathogens Testing, Heavy Metals Testing, Nutritional Labeling, GMO Testing, Pesticides Testing, Mycotoxins Testing, Organic Contaminants Testing, Others), Technology (Culture Media, Polymerase Chain Reaction, Immunoassay, Chromatography, Biochip/Biosensor, Flow Cytometry, Microarrays, Others), Food Categories

Global biochips market is forecasted to reach US$11.4 billion by 2018 with a CAGR of 18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific followed by the European Union. Among the major industry segments, biochips instruments are expected to exert the highest support to the industry with a CAGR of 20% globally.

The Global and Chinese Biochips Industry, 2011-2021 Market Research Report is a professional and in-depth study on the current state of the global Biochips industry with a focus on the Chinese market.

This report describes the global market size of Biochip from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.

A rise in the incidences of bloodstream infections (BSI), sepsis, and environment borne diseases around the world have majorly contributed to the growth of the market. Apart from this, the increasing cases of bacterial infections like tuberculosis (TB) in developing and underdeveloped countries are fueling the demand for bacterial culture tests. For more information, request for a free sample report here: https://www.imarcgroup.com/blood-culture-test-market/requestsample

The Indian seed market has witnessed a major restructuring as a result of the implementation of some progressive policies by the government. See how the research and development areas of seed industries are working and impacting the Indian seed markets. For more info visit us - https://www.aarkstore.com

Global Food Safety Testing Market is expected to reach USD 22,327.02 million by 2025 from USD 12,760.00 million in 2017, at a CAGR of 7.5% in the forecast period 2018 to 2025.

Biochemical reagents are also known as organic compounds or biological materials associated with clinical diagnostics, medical research reagents, and life science research. Most biochemical reagents are widely used in every sector of life sciences and healthcare industries resulting in rapid expansion of biochemical reagents market.

Biochip products are made up of microarrays of biochemical molecules, which are arranged on silicon or glass plate. These products have applications in gene sequencing, clinical diagnosis, genomics, proteomics, and drug discovery. Based on a biological material attached to the surface of chip, these products are categorized as tissue biochips, DNA biochips, Protein biochips, carbohydrate biochips and lab-on-chips. To view the full report visit at: http://www.researchbeam.com/biochips-market

World Biochip Markets Move to Genetic-Based Medicine Spurs Demand for Microarray Biochips Research initiatives such as the Human Genome Project and the increasing ...

Research and Investment Prospect of China Food Safety Testing Industry, 2014-2018 mainly includes development status of food safety testing industry both in China and overseas, the current China’s demand market size, technical status, competitive landscape, development opportunities and trend analysis, analyses on development status of China’s food industry and brief introduction of leading institutions in China food safety testing industry and their institution settings.

The report on Drug Discovery Technologies Market by technology type (biochips, high throughput screening, pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology), end users (biopharmaceutical, pharmaceutical, research institutes and biotech companies) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Drug Discovery Technologies Market is projected to grow at a CAGR of 18.4% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

The Global Biochips Market size is expected to reach $20.3 billion by 2025, rising at a market growth of 11.2% CAGR during the forecast period. Biochips are miniaturized medical devices used within molecular laboratories to conduct simultaneous biochemical reactions. These devices can rapidly screen multiple biological analytes for several applications like disease diagnosis and identification of hazardous biological agents existing in systems. Their design is based on microarray and microfluidic technologies. Among the two, digital microfluidic biochip has surfaced as a highly efficient chip and has gained huge traction in the biochemical industry. Full Report: https://www.kbvresearch.com/biochips-market/

Global Biochip Market is a meticulously undertaken study. Experts with proven credentials and a high standing within the research fraternity have presented an in-depth analysis of the subject matter, bringing to bear their unparalleled domain knowledge and vast research experience. Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/75533 . Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-biochip-market-2016-industry-trend-and-forecast-2021 .

The Global Biochips Market held a market value of USD 7,300 million in 2017 and is projected to grow at a CAGR of 16.6% over the forecast period.

The research study on Global Biochip Consumption 2016 Market Research Report by DecisionDatabases.com analyses the complete value chain of the Industry.

Big Market Research adds a report “Biochips Market in North America- Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2018" Know More @ http://www.bigmarketresearch.com/biochips-in-north-america-2014-2018-market Biochips market in North America to grow at a CAGR of 10.24 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need for high-speed diagnosis. The Biochips market in North America has also been witnessing the increasing outsourcing activities by drug manufacturers. Enquire about report @ http://www.bigmarketresearch.com/report-enquiry/17487

The biochip market is expected to witness significant growth throughout the forecast period because of an increasing application of biochips in genomics, proteomics and drug discovery.

Biochip is a miniaturized medical device used in molecular laboratories to carry out several biochemical reactions simultaneously.

Biochip is a miniaturized medical device used in molecular laboratories to carry out several biochemical reactions simultaneously.

Biochip is a miniaturized medical device used in molecular laboratories to carry out several biochemical reactions simultaneously. It can rapidly screen a number of biological analytes for an array of applications such as disease diagnosis and detection of hazardous biological agents in a system

Europe Food Safety Testing Market, By Testing Type (Allergen Testing, Pathogens Testing, GMO Testing, Mycotoxins Testing, Nutritional Labeling, Heavy Metals Testing, Pesticides Testing, Organic Contaminants Testing, and Others), Technology (Culture Media, Polymerase Chain Reaction, Immunoassay, Chromatography, Biochip/Biosensor, Microarrays, Flow Cytometry, and Others), Application (Food, Cereals & Grains, Oilseeds & Pulses, Nuts, and Beverages)

According to the latest research report by IMARC Group, The global separation systems for commercial biotechnology market size reached US$ 26.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 42.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.24% during 2024-2032. More Info:- https://www.imarcgroup.com/separation-systems-for-commercial-biotechnology-market

A report on “2015-2019 Future Horizons and Growth Strategies in the German Hospital Hemostasis Diagnostic Testing Market: Supplier Shares and Country Forecasts” added by Research Beam Visit at: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-german-hospital-hemostasis-diagnostic-testing-supplier-shares-and-country-forecasts-market

Read here the latest updates on the U.S. BIOCHIP PRODUCT & SERVICES MARKET ANALYSIS published by CMI team.

The study segments the Animal Genetic Products industry in light of major classification such as product type, potential markets, application, and end-user.

Nanotechnology in Medical Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nanotechnology in Medical Devices market will be able to gain the upper hand as they use the report as a powerful resource.

Molecular diagnostics is being driven by several growth factors, which include the need for automated and easy-to-handle techniques, which combine optimized sample preparation, analysis and data evaluation, and the growing availability of molecular diagnostic tests for monitoring the therapeutic efficacy of expensive drugs. Additionally, the requirement of swift diagnoses techniques that would diagnose disease condition, medical disorders quickly and offer a strong and consistent tool for quick therapy decisions represents the other key factor. Introduction of new diagnostics tests, primarily in the infectious disease application area is likely to keep the momentum going for the molecular diagnostics business in the short-term. Complete report available at: http://www.marketreportsonline.com/500816.html

Marketreportsonchina.com presents a report on “Global Proteomics Market : Company Profiles and Forecast 2015 - 2021”. http://www.marketreportsonchina.com/life-sciences-market-research-reports-18406/global-proteomics-united-states-canada-india-china-japan-united-kingdom.html Proteomic instrumentation market is dominated by proteomic microarray, accounting for around 50% of the revenue followed by spectroscopy techniques.

The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The next five years will witness significant developments in molecular diagnostics such as automation, as well as introduction of a wide range of new products. Molecular Diagnostics involves multiple technologies to identify genetic variations in individual patients. These technologies include PCR, FISH, hybrid capture, sequencing and microarrays. The increase in the aging population and incidences of various chronic diseases are driving the demand of molecular diagnostics world over. The industry is getting a push from every side and many factors collectively are fuelling the growth in this industry. Growing with a CAGR of 14.64 percent global molecular diagnostics market is expected to double its market size in 2017 from the market of 2012.

Increasing prevalence of cancer will surge the demand in future. As per WHO prediction, deaths due to cancer will escalate up to 13 million by 2030. The technology of biochip is extremely helpful in cancer drugs development. In addition, the research conducted and some ongoing research studies along with appropriate funding provided by private and government organizations is propelling business growth. For instance, in 2012, the Institute of Bioengineering and Nanotechnology of Singapore developed miniaturized biochip to help in detection of resistant drug for cancerous cells.

Big Market Research has announced a new Report Package "World Heparin Testing Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/2015-world-heparin-testing-ambulatory-centers-commercial-labs-hospitals-physician-offices-poc-point-of-care-locations-competitive-landscape-country-segment-forecasts-innovative-technologies-instrument-market The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/330944

Biochips were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence seen an influx of players vying fiercely for a share of this market. The global biochips market is studied by the types and key applications. It was valued at $2.6 billion in 2010 and is expected to reach $5.6 Billion by 2015;

EMEA Biochip Market 2017- New Study Highlights Investment Suitability & Geographical Analysis

This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales forecasts by country and market segment. Get full access of the report: http://www.researchbeam.com/european-pap-smear-hpv-2015-market

Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 to 2018. It is expected that personalized medicine diagnostics market by technology is going to double by 2018 from its current market size in 2012. In this segment, Point of Care Testing and Molecular Diagnostics segments control the #1 and #2 positions in 2012.

Hong Kong is ranked 11th and China 50th. Engineers in Society Lecture Series -0.01 ... and service IT is the fastest growing part in China's IT industry ...

The global nanotechnology-based medical devices market is segmented on the basis of products and applications. On the basis products, the nanotechnology-based medical devices market is categorized into biochips, implantable materials, medical textile and wound dressing, active implantable devices, and others. The implantable materials segment is bifurcated into dental filling materials and bone restorative materials; whereas, the active implantable devices segment is bifurcated into cardiac rhythm management devices, hearing aid devices, and retinal implants. See Full Report : http://bit.ly/1GfXr2c

Avail more information from Sample Brochure of report @ http://tinyurl.com/h8lg9pj This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales forecasts by country and market segment. Read analysis @ http://tinyurl.com/gnrvd6v

The global referral management market is estimated to grow at a CAGR of 22.1% from 2014 to 2019 to reach $2,686.3 million by 2019 from $988 million in 2014. The healthcare industry is undergoing a fundamental transformation globally as it shifts from a volume-based business to a value-based business. Growing demands from consumers for improved healthcare quality and greater value are forcing healthcare providers and payers to deliver optimized outcomes. See Full Report : http://bit.ly/1FKZ0GB

The report covers the analysis of global as well as regional markets of Drug Discovery Technologies. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.

Global Food Safety Testing Market is expected to reach USD 22,327.02 million by 2025 from USD 12,760.00 million in 2017, at a CAGR of 7.5% in the forecast period 2018 to 2025.

Global Food Safety Testing Market is expected to reach USD 22,327.02 million by 2025 from USD 12,760.00 million in 2017, at a CAGR of 7.5% in the forecast period 2018 to 2025.

Visit at: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-us-physician-office-and-group-practice-diagnostic-testing-supplier-shares-and-country-forecasts-market This report “2015-2019 Future Horizons and Growth Strategies in the Global Cell Surface Testing Market: Supplier Shares and Country Forecasts” presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.

Visit at: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-european-cell-surface-marker-testing-supplier-shares-and-country-forecasts-market The report “2015-2019 Future Horizons and Growth Strategies in the European Cell Surface Marker Testing Market: Supplier Shares and Country Forecasts” presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by country and market segment.

The report “Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019”,The Global Nanotechnology in MD Market is was valued at around $5 Billion in 2014 and expected to reach around $8.5 Billion by 2019 with a CAGR of around 11-12% during the forecast period 2014 - 2019.

An exhaustive research report on “Nano Healthcare Technology for Medical Equipment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)” skilfully crafted by Persistence Market Research focuses on various facets of the global market based on which guidelines can be slated with a view to achieve an edge over the competition as well as stability even in the unstable market conditions.

The rising global incidences of infectious diseases, increasing technological advancements and growing prevalence of chronic disorders are major factors expected to drive the market in the forecast period.

Global Biochips market Click to Get Sample @ http://goo.gl/NWSjx4 . It is categorized into four major segments, namely, hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutes, and other end users (blood banks, CROs, forensic labs, point-of-care settings, home health agencies, nursing homes, and local public health laboratories). Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Illumina, Inc. (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and F. Hoffmann-La Roche AG (Switzerland) are the major players in the biochips market.

A closer look at the aspects including but not limited to DNA and Gene Chip Market segmentation by the end-user, end-use, geography, type, and application forms an integral part of the research report.

The proteomics market is projected to reach USD 128 billion by 2032, driven by advancements in technologies, growing investments in research, and increasing demand for personalized medicine. This comprehensive analysis covers market revenue, pricing trends, market share distribution, and expected growth rates. The forecast highlights key drivers, challenges, and opportunities that will shape the market landscape over the next decade.

The Functional/Graphical Printing Market size is estimated to reach more than US$45.8 billion by 2027, after growing at a CAGR of 18.6% during the forecast period 2022-2027.